Original Research

Published on 03 Jun 2024

Feasibility exploration of GSH in the treatment of acute hepatic encephalopathy from the aspects of pharmacokinetics, pharmacodynamics, and mechanism

in Neuropharmacology

Kangrui Hu
Yexin Xu
Jiye Fan
Huafang Liu
Chanjuan Di
Feng Xu
Linlin Wu
Ke Ding
Tingting Zhang
Leyi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1387409

339 views

Mini Review

Published on 03 Jun 2024

A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity

in Neuropharmacology

Catherine K. Wang
Gio Kim
Lily R. Aleksandrova
William J. Panenka
Alasdair M. Barr

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1387158

737 views

Original Research

Accepted on 31 May 2024

Exploring Novel Natural Compound-Based Therapies for Duchenne Muscular Dystrophy Management: Insights from Network Pharmacology, QSAR modeling, Molecular Dynamics, and Free energy calculations

in Neuropharmacology

Mohd Saeed
Ashanul Haque
Ambreen Shoaib
Syed Mohd Danish Rizvi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1395014

Mini Review

Published on 31 May 2024

Novel targets and therapies of metformin in dementia: old drug, new insights

in Neuropharmacology

Wenxing Cui
Chen Lv
Panling Geng
Mingdi Fu
Wenjing Zhou
Mingxiang Xiong
Tian Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1415740

520 views

Review

Published on 30 May 2024

Pharmacological mTOR inhibitors in ameliorating Alzheimer’s disease: current review and perspectives

in Neuropharmacology

Pei-Lun Xie
Meng-Yu Zheng
Ran Han
Wei-Xin Chen
Jin-Hua Mao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1366061

761 views

Original Research

Published on 30 May 2024

Edaravone dexborneol attenuates oxidative stress in experimental subarachnoid hemorrhage via Keap1/Nrf2 signaling pathway

in Neuropharmacology

Kunyuan Zhu
Shijun Bi
Zechao Zhu
Wenxu Zhang
Xinyu Yang
Jiashuo Li
Guobiao Liang
Chunyong Yu
Pengyu Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1342226

478 views

Original Research

Published on 30 May 2024

Development of a new hazard scoring system in primary neuronal cell cultures for drug-induced acute neuronal toxicity identification in early drug discovery

in Neuropharmacology

Mohamed Kreir
Dea Putri
Fetene Tekle
Francesca Pibiri
Constantin d’Ydewalle
Karel Van Ammel
Helena Geys
Ard Teisman
David J. Gallacher
Hua Rong Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1308547

382 views

Original Research

Published on 27 May 2024

Adenosine A2A and dopamine D2 receptor interaction controls fatigue resistance

in Neuropharmacology

Ana Cristina de Bem Alves
Naiara de Souza Santos
Ana Paula Tavares Santos
Gabriela da Panatta
Ana Elisa Speck
Rodrigo A. Cunha
Aderbal S. Aguiar

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1390187

493 views

Review

Published on 27 May 2024

Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities

in Neuropharmacology

Chi Ma
Dan Liu
Benqiao Wang
Yingying Yang
Ruixia Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1370411

553 views

Review

Published on 24 May 2024

Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action

in Neuropharmacology

Abdul Waris
Ata Ullah
Muhammad Asim
Rafi Ullah
Md. Rafe Rajdoula
Stephen Temitayo Bello
Fahad A. Alhumaydhi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403232

901 views

Systematic Review

Published on 24 May 2024

Global research status and trends of enteric glia: a bibliometric analysis

in Neuropharmacology

Huai-Yu Li
Wei-Xin Yan
Jia Li
Jing Ye
Zhi-Guo Wu
Zheng-Kun Hou
Bin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403767

521 views

Review

Published on 24 May 2024

Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease

in Neuropharmacology

Chinenye Edith Muolokwu
Bivek Chaulagain
Avinash Gothwal
Arun Kumar Mahanta
Benjamin Tagoe
Babita Lamsal
Jagdish Singh

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1405423

1,457 views

Clinical Trial

Published on 24 May 2024

Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study

in Neuropharmacology

Khlood Mohammad Aldossary
Lashin Saad Ali
Mahmoud S. Abdallah
Mostafa M. Bahaa
Thanaa A. Elmasry
Eman I. Elberri
Fedaa A. Kotkata
Ramy M. El Sabaa
Yasmine M. Elmorsi
Mostafa M. Kamel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1381523

764 views

Review

Published on 24 May 2024

Alzheimer’s disease and its treatment–yesterday, today, and tomorrow

in Neuropharmacology

A. Y. Kim
S. Al Jerdi
R. MacDonald
C. R. Triggle

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1399121

2,094 views

Original Research

Published on 23 May 2024

Effects of long-term antipsychotic medication on brain instability in first-episode schizophrenia patients: a resting-state fMRI study

in Neuropharmacology

Maoxing Zhong
Zhening Liu
Feiwen Wang
Jun Yang
Eric Chen
Edwin Lee
Guowei Wu
Jie Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1387123

391 views

Review

Published on 22 May 2024

Drug-induced musical hallucination

in Neuropharmacology

Brock Bakewell
Michael Johnson
Madison Lee
Elizabeth Tchernogorova
Jesse Taysom
Qing Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401237

777 views

Navigation group

Articles

Feasibility exploration of GSH in the treatment of acute hepatic encephalopathy from the aspects of pharmacokinetics, pharmacodynamics, and mechanism

A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity

Exploring Novel Natural Compound-Based Therapies for Duchenne Muscular Dystrophy Management: Insights from Network Pharmacology, QSAR modeling, Molecular Dynamics, and Free energy calculations

Novel targets and therapies of metformin in dementia: old drug, new insights

Pharmacological mTOR inhibitors in ameliorating Alzheimer’s disease: current review and perspectives

Edaravone dexborneol attenuates oxidative stress in experimental subarachnoid hemorrhage via Keap1/Nrf2 signaling pathway

Development of a new hazard scoring system in primary neuronal cell cultures for drug-induced acute neuronal toxicity identification in early drug discovery

Adenosine A2A and dopamine D2 receptor interaction controls fatigue resistance

Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities

Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action

Global research status and trends of enteric glia: a bibliometric analysis

Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease

Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study

Alzheimer’s disease and its treatment–yesterday, today, and tomorrow

Effects of long-term antipsychotic medication on brain instability in first-episode schizophrenia patients: a resting-state fMRI study

Drug-induced musical hallucination